Literature DB >> 30194657

Ameliorative effect of Xiaoyao-jieyu-san on post-stroke depression and its potential mechanisms.

Changde Wang1, Chunlan Wu2, Zhenguo Yan2, Xiao Cheng2.   

Abstract

A stroke is a severe life-threatening disease with high fatality and disability rate. This investigation aimed to study the effect of Xiaoyao-jieyu-san (XYJY) on post-stroke depression (PSD) and its potential mechanisms. PSD rats were prepared using middle cerebral artery embolization (MCAO) and chronic unpredictable mild stress (CUMS), and divided into six groups (n = 10)-sham; MCAO; MCAO + CUMS (PSD); PSD + fluoxetine (1.84 mg/kg/day, 4 weeks); and PSD + XYJY (450 mg/kg/day and 900 mg/kg/day, 4 weeks). Body weight recording, despair swimming test, and sucrose preference test were performed at 0, 3 and 7 weeks. Histopathological examination and levels of 5-hydroxytryptamine (5-HT), norepinephrine (NE) and brain-derived neurotrophic factor (BDNF) in ventral tegmental area-nucleus accumbens (VTA-NAc) tissue were determined at the end of a 7-week period. Real-time polymerase chain reaction PCR was used to determine mRNA expression of 5-HT1AR and 5-HT2AR, and Western blot was performed to determine expression of BDNF, corticotrophin-releasing factor (CRF), and cannabinoid receptors (CB1R and CB2R) in VTA-NAc tissue. High-performance liquid chromatography coupled with electrospray mass spectroscopy revealed that the constituents of XYJY are mainly paeoniflorin, imperatorin, naringin, arnesene, 2,3,5,4'-tetrahydroxyl-diphenylethylene-2-O-glucoside, kaempferol-3-O-rutinoside, quercetin, hesperidin, cycloastragenol and atractylenolide III. XYJY (900 mg/kg) increased the body weight of PSD rats, while XYJY (450 mg/kg and 900 mg/kg) shortened the duration of immobility and enhanced the sucrose preference of PSD rats. XYJY (450 mg/kg and 900 mg/kg) increased the levels of 5-HT, NE and BNDF, up-regulated mRNA expression of 5-HT1AR, down-regulated 5-HT2AR, and up-regulated BNDF, CB1R, and CB2R expression in the VTA-NAc tissue of PSD rats but down-regulated CRF. Collectively, the present findings suggested that XYJY has an ameliorative effect on PSD in rats via modulation of BNDF, cannabinoid receptors and CRF in VTA-NAc tissue.

Entities:  

Keywords:  Brain-derived neurotrophic factor; Cannabinoids receptors; Corticotropin-releasing factor; Post-stroke depression; Xiaoyao-jieyu-san

Mesh:

Substances:

Year:  2018        PMID: 30194657     DOI: 10.1007/s11418-018-1243-5

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  23 in total

1.  Ethnopharmacology and drug discovery.

Authors:  Bhushan Patwardhan
Journal:  J Ethnopharmacol       Date:  2005-08-22       Impact factor: 4.360

2.  Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.

Authors:  B Chen; D Dowlatshahi; G M MacQueen; J F Wang; L T Young
Journal:  Biol Psychiatry       Date:  2001-08-15       Impact factor: 13.382

3.  Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice.

Authors:  Karolina Pekala; Agnieszka Michalak; Marta Kruk-Slomka; Barbara Budzynska; Grazyna Biala
Journal:  Behav Brain Res       Date:  2018-03-15       Impact factor: 3.332

4.  Role of hypothalamic cannabinoid receptors in post-stroke depression in rats.

Authors:  Shanshan Wang; Hong Sun; Sainan Liu; Ting Wang; Jinqun Guan; Jianjun Jia
Journal:  Brain Res Bull       Date:  2016-01-14       Impact factor: 4.077

5.  Effects of stroke rehabilitation on incidence of poststroke depression: a population-based cohort study.

Authors:  Wen-Hsuan Hou; Huey-Wen Liang; Ching-Lin Hsieh; Chieh-Yi Hou; Pei-Chun Wen; Chung-Yi Li
Journal:  J Clin Psychiatry       Date:  2013-09       Impact factor: 4.384

6.  Antidepressant-like effects of essential oil and asarone, a major essential oil component from the rhizome of Acorus tatarinowii.

Authors:  Ping Han; Ting Han; Wei Peng; Xiao-Ru Wang
Journal:  Pharm Biol       Date:  2013-01-31       Impact factor: 3.503

Review 7.  Cannabinoid Modulation of the Stressed Hippocampus.

Authors:  Franciele F Scarante; Carla Vila-Verde; Vinícius L Detoni; Nilson C Ferreira-Junior; Francisco S Guimarães; Alline C Campos
Journal:  Front Mol Neurosci       Date:  2017-12-19       Impact factor: 5.639

8.  A Population-Based Cohort Study on the Ability of Acupuncture to Reduce Post-Stroke Depression.

Authors:  Shuo-Ping Tseng; Yu-Ching Hsu; Ching-Ju Chiu; Shang-Te Wu
Journal:  Medicines (Basel)       Date:  2017-03-15

9.  Improvement of Antioxidant Defences and Mood Status by Oral GABA Tea Administration in a Mouse Model of Post-Stroke Depression.

Authors:  Maria Daglia; Arianna Di Lorenzo; Seyed Fazel Nabavi; Antoni Sureda; Sedigheh Khanjani; Akbar Hajizadeh Moghaddam; Nady Braidy; Seyed Mohammad Nabavi
Journal:  Nutrients       Date:  2017-04-29       Impact factor: 5.717

10.  Comparative Researches of Semen Arecae and Charred Semen Arecae on Gastrointestinal Motility, Motilin, Substance P, and CCK in Chronically Stressed Rats.

Authors:  Sanyin Zhang; Peng Yang; Xixiong Li; Xin Wang; Jiage Song; Wei Peng; Chunjie Wu
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-11       Impact factor: 2.629

View more
  8 in total

1.  lncRNA MIR155HG Alleviates Depression-Like Behaviors in Mice by Regulating the miR-155/BDNF Axis.

Authors:  Zhang Huan; Zhu Mei; Huang Na; Ma Xinxin; Wang Yaping; Liu Ling; Wang Lei; Zhang Kejin; Liu Yanan
Journal:  Neurochem Res       Date:  2021-01-29       Impact factor: 3.996

2.  Antistress Effects of San-Huang-Xie-Xin Decoction on Restraint-Stressed Mice Revealed by 1H NMR-Based Metabolomics and Biochemistry Analysis.

Authors:  Wei Peng; Huan Du; Guangli Liu; Qing Zhang; Tingting Kuang; Zhang Wang; Gang Fan
Journal:  Oxid Med Cell Longev       Date:  2019-04-16       Impact factor: 6.543

Review 3.  Research Progress on Classical Traditional Chinese Medicine Jieyu Pills in the Treatment of Depression.

Authors:  Yuan Wang; Miao Peng
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-08       Impact factor: 2.570

4.  Electroacupuncture Ameliorates Depressive-Like Behaviors in Poststroke Rats via Activating the tPA/BDNF/TrkB Pathway.

Authors:  Hao Dong; Yan-Qiang Qin; Ying-Chun Sun; Hai-Jiang Yao; Xian-Kuan Cheng; Yan Yu; Shou-Si Lu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-13       Impact factor: 2.570

5.  Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway.

Authors:  Yue Xu; Weiyin Chen; Zeran Chen; Mengyuan Huang; Fang Yang; Yang Zhang
Journal:  Drug Des Devel Ther       Date:  2021-02-22       Impact factor: 4.162

Review 6.  Efficacy and Safety of Xiaoyao Recipe in the Treatment of Poststroke Depression: A Systematic Review and Meta-Analysis.

Authors:  Dou Wang; Tao Li; Jie Ron; Meiling Mao; Yifan Yang; Yalun Feng; Yongmei Yan
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-13       Impact factor: 2.650

Review 7.  Microglia Involves in the Immune Inflammatory Response of Poststroke Depression: A Review of Evidence.

Authors:  Weili Xia; Yong Xu; Yuandong Gong; Xiaojing Cheng; Tiangui Yu; Gongchang Yu
Journal:  Oxid Med Cell Longev       Date:  2022-08-02       Impact factor: 7.310

Review 8.  Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression.

Authors:  Jianbei Chen; Chaofang Lei; Xiaojuan Li; Qian Wu; Chenyue Liu; Qingyu Ma; Jiaxu Chen
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.